Wednesday, 17 July 2019

Drug Discovery News

  • Nuvilex, Lincoln Park Fund sign $27 mn stock deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2014

    Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, entered into a stock purchase agreement with Linco...Read more

  • Korea to spend $8.9 bn to develop 20 drugs by 2017

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: South Korea will channelize a combined $8.9 billion (10 trillion Won) on developing 20 new drugs over the next five years, and this will be done in collaboration with private loc...Read more

  • Abbott reveals 10-year study data for HUMIRA

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: Abbott revealed the results from two long-term, open-label studies, which evaluated the results of HUMIRA (adalimumab) treatment for up to 10 years in patients with long-standing...Read more

  • Edinburgh Univ, Biogen to study neuro diseases

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Experts from University of Edinburgh, UK, and Massachusetts-based biotechnology company Biogen Idec have joined hands to seek greater insight into multiple sclerosis and motor ne...Read more

  • Admedus acquires Genzyme manufacturing site

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2013

    Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufacturing site from Genzyme Australasia, a Sanofi company. Admedus recei...Read more

  • AstraZeneca halts development of obesity drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: Palatin Technologies collaboration with AstraZeneca is to be discontinued for the further development of AZD2820, one of the many compounds that were jointly being developed for ...Read more

  • Trajenta shows blood glucose improvements

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Results from a two-year study has demonstrated that Boehringer Ingelheim's Trajenta (linagliptin) provides similar blood glucose improvements when compared to the commonly prescr...Read more

  • One drug for three diseases

    Drug Discovery |  Opinion | By Nandita Singh | 0 Comment | 01 Aug, 2012

    VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF 723 - when taken up by a cell. The HGF has two very important biologi...Read more

  • China invests $160 bn in biomedicine sector

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: A report filed by Lux Research that tracks emerging technologies has said that China has invested a staggering $160 billion into its biomedicine sector in an effort to catch up w...Read more

  • BioDiem gets positive results for eye disease drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem received positive results from formal studies of its BDM-E eye disease drug. The results were presen...Read more

  • Australia strengthens scientific collaboration with Indonesia

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Australian Academy of Science and the Indonesian Academy of Sciences have signed a new memorandum of understanding (MOU) on Scientific Cooperation. President of Australian Academ...Read more

  • China, Taiwan firms join hands for cancer drugs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Taiwan's PharmaEngine has signed research collaboration with Guangzhou BeBetter Medicine Technology to design, synthesize and develop new chemical entities against predefined tar...Read more

  • Amgen terminates AstraZeneca psoriasis drug partnership

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

    Singapore: Amgen has terminated the partnership with AstraZeneca for co-development and commercialization of brodalumab, an investigational IL-17 inhibitor for patients with moderate-to-sev...Read more

  • UCLA finds new compound to curb Alzheimer's

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular compound, CLR01, which has been found to prevent toxic proteins from...Read more

  • Dainippon, Nippon Shinyaku sign deal for new drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive rights to develop, manufac...Read more

  • AVEO, Astellas file NDA for tivozanib

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tivozanib in patients wit...Read more

  • Sanofi seeks approval for Lyxumia in Japan

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational once-daily GLP-1 receptor agonist, to the Ministry of Health, Labour ...Read more

  • Cadila, Swedish firm develop arthritis drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2014

    Singapore: NovaSAID, part of Sweden-based Karolinska Development, and India- based Cadila Pharmaceuticals have entered into a strategic partnership to develop new treatments for inflammatio...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls